Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Merghoub

Showing results (201-210 of 216) with videos related to

Pageof 22
Sort By:
European Urology|November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial CarcinomaKwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
Nature|November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerVinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Immunity|December 27, 2022
The ectonucleotidase CD39 identifies tumor-reactive CD8<sup>+</sup> T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Fathema Z Uddin, Michael Liu, et al.
Cancer Immunology Research|January 7, 2026
IL-10R inhibition induces neutrophil tumoricidal activityDanny N Khalil, Ricardo Gomez, Amit Regev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLCMatthew D Hellmann, Barzin Y Nabet, Hira Rizvi, et al.
Cancer Cell|June 11, 2021
Tim-4<sup>+</sup> cavity-resident macrophages impair anti-tumor CD8<sup>+</sup> T cell immunityAndrew Chow, Sara Schad, Michael D Green, et al.
Cell|October 10, 2020
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen PredictionDaniel K Wells, Marit M van Buuren, Kristen K Dang, et al.
Nature|February 19, 2025
RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancerZachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Pageof 22

Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
European Urology|November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial CarcinomaKwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
Nature|November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerVinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Immunity|December 27, 2022
The ectonucleotidase CD39 identifies tumor-reactive CD8<sup>+</sup> T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Fathema Z Uddin, Michael Liu, et al.
Cancer Immunology Research|January 7, 2026
IL-10R inhibition induces neutrophil tumoricidal activityDanny N Khalil, Ricardo Gomez, Amit Regev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLCMatthew D Hellmann, Barzin Y Nabet, Hira Rizvi, et al.
Cancer Cell|June 11, 2021
Tim-4<sup>+</sup> cavity-resident macrophages impair anti-tumor CD8<sup>+</sup> T cell immunityAndrew Chow, Sara Schad, Michael D Green, et al.
Cell|October 10, 2020
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen PredictionDaniel K Wells, Marit M van Buuren, Kristen K Dang, et al.
Nature|February 19, 2025
RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancerZachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Pageof 22